The cardiovascular form of autonomous neuropathy in the adolescents with type 2 diabetes mellitus

Objective. To estimate the prevalence of the cardiovascular form of autonomous neuropathy (CAN) and the factors associated with this condition in the adolescents suffering from type 2 diabetes mellitus (DM2) in comparison to the adolescents present- ing with type 1 diabetes mellitus (DM1). Material and methods. The study included 24 adolescents with DM2 and 30 ones with DM1 matched for the age, duration of the disease, and the quality of its compensation. The control group was comprised of 17 adolescents with exogenous constitutional obesity (ECO). All the patients were examined by means of Holter ECG monitoring with the estimation of the daily cardiac rhythm variability based on the mean weighted variation of rhythmogram (MWVR) and the length of the QTc interval. In addition, standard cardiovascular tests were performed including deep-breath test, the Valsalva maneuver, and the 30:15 intermittent fitness test. Cardiovascular autonomous neuropathy was diagnosed in the patients exhibiting deviation from the normal values in 3 of the five parameters of interest, viz. MWVR, QTc length, and three functional tests. Results. CAN at the subclincal stage was more frequently diagnosed in the adolescents with DM2 than in those suffering DM1 (29.2 and 10% of the cases respectively; p<0.05). This condition was not found in any of the patients presenting with endogenous constitutional obesity. MWVR in the adolescents with DM2 was lower than in the patients with DM1 (p=0.02) or ECO (p=0.04). The QTc duration was greater in the DM2 patients than in the adolescents of the same age presenting with ECO (p=0.02) and comparable with that in the patients suffering DM1 (p=0.3). In the adolescents with DM2, positive correlation between CAN, the duration of diabetes, the quality of its compensation, and the patient’s age was documented while the length of the QTc interval negatively correlated with these three variables. Moreover, the occurrence of CAN positively correlated with peripheral neuropathy. No relationship with the severity of insulin resistance was observed.

adolescents, type 2 diabetes mellitus, type 1 diabetes mellitus, obesity, the cardiovascular form of autonomous neu- ropathy, cardiac rhythm variability, GTc interval

1. Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis, Diabetes Care, 2003;26(6):1895–1901. doi: 10.2337/diacare.26.6.1895

2. Dimitropoulos G, Tahrani AA, Stevens MJ. Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes. 2014;5(1):17-39. doi: 10.4239/wjd.v5.i1.17.

3. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003;26(6):1553–1579. doi: 10.2337/diacare.26.6.1895

4. Рябыкина Г.В., Соболев А.В. Холтеровское и бифункциональное мониторирование ЭКГ и артериального давления. – М.: МЕДПРАКТИКА-М; 2010. 319 с. [Ryabykina GV, Sobolev AV. Kholterovskoe i bifunktsional'noe monitorirovanie EKG i arterial'nogo davleniya. Moscow: MEDPRAKTIKA-M; 2010. 319p.]

5. Рабочая группа по подготовке текста Рекомендаций, председатель Макаров Л.М. Национальные Российские рекомендации по применению методики холтеровского мониторирования в клинической практике. // Российский кардиологический журнал. – 2014. – №2. – С. 6-71. [National russian guidelines on application of the methods of holter monitoring in clinical practice. Russian Journal of Cardiology 2014;(2):6-71.]

6. O'Brien IA, O'Hare P, Corrall RJ. Heart rate variability in healthy subjects: effect of age and the derivation of normal ranges for tests of autonomic function. Heart. 1986;55(4):348-54. doi: 10.1136/hrt.55.4.348

7. Verrotti A, Loiacono G, Mohn A, Chiarelli F. New insights in diabetic autonomic neuropathy in children and adolescents. European Journal of Endocrinology. 2009;161(6):811-8. doi: 10.1530/eje-09-0710

8. Agelink MW, Malessa R, Baumann B, Majewski T, Akila F, Zeit T, et al. Standardized tests of heart rate variability: normal ranges obtained from 309 healthy humans, and effects of age, gender, and heart rate. Clin Auton Res. 2001;11(2):99-108. doi: 10.1007/bf02322053

9. DCCT Research Group. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia. 1998 Apr;41(4):416-423.

10. Kempler P, Tesfaye S, Chaturvedi N, Stevens LK, Webb DJ, Eaton S, et al. Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study. Diabetic Medicine. 2002;19(11):900-909. doi: 10.1046/j.1464-5491.2002.00821.x

11. Ziegler D, Laux G, Dannehl K, Spüler M, Mühlen H, Mayer P, et al. Assessment of Cardiovascular Autonomic Function: Age-related Normal Ranges and Reproducibility of Spectral Analysis, Vector Analysis, and Standard Tests of Heart Rate Variation and Blood Pressure Responses. Diabetic Medicine. 1992;9(2):166-175. doi: 10.1111/j.1464-5491.1992.tb01754.x

12. O'Brien IA, McFadden JP, Corrall RJ. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Quarterly Journal of Medicine. 1991 Jun;79(290):495-502.

13. Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R, et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes/Metabolism Research and Reviews. 2011;27(7):639-653. doi: 10.1002/dmrr.1239

14. Veglio M, Borra M, Stevens LK, Fuller JH, Perin PC. The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group. Diabetologia. 1999;42(1):68-75. doi: 10.1007/s001250051115

15. Schwartz PJ, Stramba-Badiale M, Segantini A, Austoni P, Bosi G, Giorgetti R, et al. Prolongation of the QT Interval and the Sudden Infant Death Syndrome. New England Journal of Medicine. 1998;338(24):1709-1714. doi: 10.1056/nejm199806113382401

16. de Bruyne M. Prolonged QT interval predicts cardiac and all-cause mortality in the elderly The Rotterdam Study. European Heart Journal. 1999;20(4):278-284. doi: 10.1053/euhj.1998.1276

17. Whitsel EA, Boyko EJ, Siscovick DS. Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes: a meta-analysis. Diabetes Care. 2000;23(2):241-247. doi: 10.2337/diacare.23.2.24

18. Рябыкина Г.В., Лаптев Д.Н., Соболев А.В., Сеид-Гуссейнов А.А., Волков И.Э. Исследование интервала QT у детей и подростков, больных сахарным диабетом 1 типа, при холтеровском мониторировании ЭКГ. // Сахарный диабет. – 2007. – №2. – С. 19-23. [Ryabykina GV, Laptev DN, Sobolev AV, Seid-Gusseynov AA, Volkov IE. Issledovanie intervala QTu detey i podrostkov, bol'nykh sakharnymdiabetom 1 tipa, pri kholterovskommonitorirovanii EKG. Diabetes mellitus. 2007;(2):19-23.] doi: 10.14341/2072-0351-5791

19. Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AAF, Feldman EL. Elevated Triglycerides Correlate With Progression of Diabetic Neuropathy. Diabetes. 2009;58(7):1634-1640. doi: 10.2337/db08-1771

20. Voulgari C, Psallas M, Kokkinos A, Argiana V, Katsilambros N, Tentolouris N. The association between cardiac autonomic neuropathy with metabolic and other factors in subjects with type 1 and type 2 diabetes. Journal of Diabetes and Its Complications. 2011;25(3):159-167. doi: 10.1016/j.jdiacomp.2010.06.001

21. Rosenbloom AL, Silverstein JH, Amemiya S, Zeitler P, Klingensmith GJ. Type 2 diabetes mellitus in the child and adolescent. Pediatric Diabetes. 2008;9(5):512-526. doi: 10.1111/j.1399-5448.2008.00429.x

22. McGrath NM, Parker GN, Dawson P. Early presentation of type 2 diabetes mellitus in young New Zealand Maori. Diabetes Research and Clinical Practice. 1999;43(3):205-209. doi: 10.1016/s0168-8227(99)00003-0

23. Eppens MC. Prevalence of Diabetes Complications in Adolescents With Type 2 Compared With Type 1 Diabetes. Diabetes Care. 2006;29(6):1300-1306. doi: 10.2337/dc05-2470

24. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Sustained Effect of Intensive Treatment of Type 1 Diabetes Mellitus on Development and Progression of Diabetic Nephropathy. JAMA. 2003;290(16):2159. doi: 10.1001/jama.290.16.2159

25. Scott A, Toomath R, Bouchier D, Bruce R, Crook N, Carroll D, et al. First national audit of the outcomes of care in young people with diabetes in New Zealand: high prevalence of nephropathy in Maori and Pacific Islanders. New Zealand Medical Journal. 2006;119(1235):U2015.

26. Yoo EG, Choi IK, Kim DH. Prevalence of Microalbuminuria in Young Patients with Type 1 and Type 2 Diabetes Mellitus. Journal of Pediatric Endocrinology and Metabolism. 2004;17(10). doi: 10.1515/jpem.2004.17.10.1423

27. Yokoyama H, Okudaira M, Otani T, Watanabe C, Takaike H, Miuira J, et al. High incidence of diabetic nephropathy in early-onset Japanese NIDDM patients. Risk analysis. Diabetes Care. 1998;21(7):1080-1085. doi: 10.2337/diacare.21.7.1080

28. Ettinger LM, Freeman K, DiMartino-Nardi JR, Flynn JT. Microalbuminuria and Abnormal Ambulatory Blood Pressure in Adolescents With Type 2 Diabetes Mellitus. The Journal of Pediatrics. 2005;147(1):67-73. doi: 10.1016/j.jpeds.2005.02.003

29. Karabouta Z, Barnett S, Shield JPH, Ryan FJ, Crowne EC. Peripheral neuropathy is an early complication of type 2 diabetes in adolescence. Pediatric Diabetes. 2008;9(2):110-114. doi: 10.1111/j.1399-5448.2007.00339.x

30. Jaiswal M, Lauer A, Martin CL, Bell RA, Divers J, Dabelea D, et al. Peripheral Neuropathy in Adolescents and Young Adults With Type 1 and Type 2 Diabetes From the SEARCH for Diabetes in Youth Follow-up Cohort: A pilot study. Diabetes Care. 2013;36(12):3903-3908. doi: 10.2337/dc13-1213

31. Maser RE, Lenhard MJ. Cardiovascular Autonomic Neuropathy Due to Diabetes Mellitus: Clinical Manifestations, Consequences, and Treatment. The Journal of Clinical Endocrinology & Metabolism. 2005;90(10):5896-5903. doi: 10.1210/jc.2005-0754

32. Gæde P, Vedel P, Larsen N, Jensen GVH, Parving H-H, Pedersen O. Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes. New England Journal of Medicine. 2003;348(5):383-393. doi: 10.1056/NEJMoa021778

33. Istenes I, Keresztes K, Hermnyi Z, Putz Z, Vargha P, Gandhi R, et al. Relationship between autonomic neuropathy and hypertensionare we underestimating the problem? Diabetic Medicine. 2008;25(7):863-866. doi: 10.1111/j.1464-5491.2008.02458.x